Revolutionary Results: How Modern Weight Loss Medications are Changing the Game
Dr. Paddy Barrett
DECEMBER 12, 2023
That’s what the field of obesity therapeutics feels like right now. The primary reason for managing risk factors is to reduce events, including heart attacks. The SELECT trial is currently underway to assess whether major heart events are reduced using Semaglutide in those without a previous heart attack 5.
Let's personalize your content